Rolapitant inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets gerbil NK1, guinea pig NK1, human NK1, monkey NK1, mouse NK1, rabbit NK1, and rat NK1.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.